Laurene Meyniel-Schicklin

Title: Inventor Laurene Meyniel-Schicklin: Innovating Solutions Against Influenza Viruses

Introduction

Laurene Meyniel-Schicklin is an accomplished inventor based in Lyons, France. With a focus on pharmaceutical innovations, she has garnered attention for her work in developing methods to inhibit the replication of influenza viruses. Her dedication to scientific research and innovation has made a significant impact in the field of virology.

Latest Patents

Laurene holds one patent titled "Methods and pharmaceutical compositions for inhibiting influenza viruses replication." This groundbreaking invention encompasses various compounds, including Gemcitabine, Obatoclax Mesylate, Docetaxel, HA-14, Alsterpaullone, and several others. These compounds are specifically aimed at treating influenza infections in subjects who require effective therapeutic solutions.

Career Highlights

In her professional journey, Laurene has worked with esteemed organizations such as the Institut National de la Santé et de la Recherche Médicale and the Université Claude Bernard Lyon 1. Her tenure at these institutions showcases her commitment to advancing medical research and developing innovative therapies.

Collaborations

Throughout her career, Laurene has collaborated with notable colleagues, including Vincent Lotteau and Benoit De Chassey. These partnerships highlight the collaborative nature of scientific research, fostering an environment where innovative ideas can thrive.

Conclusion

Laurene Meyniel-Schicklin exemplifies the spirit of innovation in the medical field, particularly in her pursuit of solutions to combat influenza viruses. Her contributions through patents and collaborations underscore her position as a prominent figure in the world of scientific research and development.